Decreased respiratory performance of children and adolescents with myelomeningocele who use a wheelchair – preliminary data by E.J. Martins (7141313)

Lovastatin improves microvascular function and decreases leukocyte rolling and adhesion during PbA infection. by Patricia A. Reis (109310)

Pharmacological Characterization of a 5-HT₁-Type Serotonin Receptor in the Red Flour Beetle, <i>Tribolium castaneum</i> by Rut Vleugels (416859)

“…Real time PCR showed high expression in the brain (without optic lobes) and the optic lobes, consistent with the role of 5-HT as neurotransmitter. Activation of Trica5-HT₁ in mammalian cells decreased NKH-477-stimulated cyclic AMP levels in a dose-dependent manner, but did not influence intracellular Ca²⁺ signaling. …”

Correlates of osteogenic differentiation. by Fabian Westhauser (5314436)

Data_Sheet_1_The 5-HT6 Receptors in the Ventrolateral Orbital Cortex Attenuate Allodynia in a Rodent Model of Neuropathic Pain.pdf by Yuxiang Zhang (412465)

“…These findings suggest a potential therapeutic role of 5-HT₆ receptor agonists in treating neuropathic pain.…”

DataSheet1_Role of 5HT1A Receptors in the Neuroprotective and Behavioral Effects of Cannabidiol in Hypoxic–Ischemic Newborn Piglets.PDF by Lorena Barata (13113006)

“…These effects are thought to be related to serotonin 5-HT_1A receptor (5HT_1AR) activation. …”

Decreased GH storage and secretion in PICK1-deficient mice. by Birgitte Holst (250548)

“…(B) PICK1-deficient mice exhibited a decreased level of plasma IGF-1 (*<i>p</i><0.05). …”

Inhibition of the lysosomal protease decreased the apoptosis induced by EV71. by Xueyan Xi (5654083)

Introduction of the F region decreases the amount of extracellular PSMs and increases the amount of extracellular FnbA. by Chikara Kaito (230958)

Decreased CSF cytokine levels in α7 KO mice. by Feng Chi (170688)

h-GAAP Decreases Cell Susceptibility to Intrinsic Apoptosis Pathways by Caroline Gubser (24818)

Nicotine decreases PDI expression in e15 rat placentas. by Michael K. Wong (646399)

Cilostazol decreases OC formation and bone resorption induced by RANKL. by Ke Ke (583325)

HDAC inhibition by TSA decreases SREBP2 proteolytic cleavage. by Maria João Nunes (160499)

Video_7_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.WMV by Henryk Majczyński (830716)

“…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT₂ (Cyproheptadine; Cypr), 5-HT_2A neutral antagonist (Volinanserin; Volin), 5-HT_2C neutral antagonist (SB 242084), and 5-HT_2B/2C inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”

Image_3_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.JPEG by Henryk Majczyński (830716)

“…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT₂ (Cyproheptadine; Cypr), 5-HT_2A neutral antagonist (Volinanserin; Volin), 5-HT_2C neutral antagonist (SB 242084), and 5-HT_2B/2C inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”

Image_2_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.JPEG by Henryk Majczyński (830716)

“…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT₂ (Cyproheptadine; Cypr), 5-HT_2A neutral antagonist (Volinanserin; Volin), 5-HT_2C neutral antagonist (SB 242084), and 5-HT_2B/2C inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”

Image_4_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.JPEG by Henryk Majczyński (830716)

“…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT₂ (Cyproheptadine; Cypr), 5-HT_2A neutral antagonist (Volinanserin; Volin), 5-HT_2C neutral antagonist (SB 242084), and 5-HT_2B/2C inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”

Video_3_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.WMV by Henryk Majczyński (830716)

“…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT₂ (Cyproheptadine; Cypr), 5-HT_2A neutral antagonist (Volinanserin; Volin), 5-HT_2C neutral antagonist (SB 242084), and 5-HT_2B/2C inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”

Video_6_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.WMV by Henryk Majczyński (830716)

“…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT₂ (Cyproheptadine; Cypr), 5-HT_2A neutral antagonist (Volinanserin; Volin), 5-HT_2C neutral antagonist (SB 242084), and 5-HT_2B/2C inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”